Sanofi (SNY) Current Assets (2009 - 2026)

Sanofi has disclosed Current Assets across 18 years of filings, most recently posting $36.6 billion for Q2 2026.

• In Q2 2026, Current Assets fell 12.56% year-over-year to $36.6 billion; the TTM figure through Jun 2026 stood at $36.6 billion (down 12.56% YoY), while the FY2025 annual figure was $36.0 billion, down 21.84% from the prior year.
• Current Assets came in at $36.6 billion for Q2 2026 at Sanofi, up from $35.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $46.3 billion in Q1 2025 to a low of $30.3 billion in Q2 2022.
• Average Current Assets over 5 years is $37.0 billion, with a median of $35.7 billion recorded in 2025.
• Year-over-year, Current Assets soared 37.91% in 2024 and fell 23.73% in 2026.
• Over 5 years, Current Assets stood at $34.8 billion in 2022, then retreated by 5.18% to $33.0 billion in 2023, then jumped by 37.91% to $45.5 billion in 2024, then dropped by 20.83% to $36.0 billion in 2025, then grew by 1.69% to $36.6 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $36.6 billion in Q2 2026, $35.3 billion in Q1 2026, and $36.0 billion in Q4 2025.